Document is current
Any future updates will be listed below
-
Authors
Goodman-Meza, David http://orcid.org/0000-0001-9382-3564
Shoptaw, Steven
Hanscom, Brett
Smith, Laramie R.
Andrew, Philip
Kuo, Irene
Lake, Jordan E.
Metzger, David
Morrison, Ellen A. B.
Cummings, Melissa
Fogel, Jessica M.
Richardson, Paul
Harris, Jayla
Heitner, Jesse
Stansfield, Sarah
El-Bassel, Nabila
,
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068619-15, UM1AI068617-15, UM1AI068613-15)
- License Information
-
More Information
Article History
Received: 1 July 2023
Accepted: 22 December 2023
First Online: 15 February 2024
Declarations
:
: This trial was approved for all sites by a central institutional review board (Advarra). All participants provided written informed consent prior to the initiation of any study activities.
: Not applicable.
: JEL, EAM, and DGM have received grant support from Gilead Sciences. SS receives clinical supplies for his research from Gilead Sciences, Alkermes, and Indivior. All other authors declare that they have no competing interests.
